NEPROCHECK
Device
bioMerieux
Total Payments
$82,339
Transactions
9
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $82,339 | 9 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $82,339 | 9 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| LAPIS Trial: A Biomarker-Guided Implementation of Kidney-Sparing Care Measures to Prevent AKI in Sepsis Patients | bioMerieux | $59,877 | 2 |
| S0036 | bioMerieux | $10,000 | 0 |
| S0025 | bioMerieux | $6,404 | 0 |
| S0028 | bioMerieux | $6,059 | 0 |
Top Doctors Receiving Payments for NEPROCHECK
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Pittsburgh, PA | $76,502 | 6 |
| , MD | Critical Care Medicine | Orlando, FL | $4,875 | 2 |
| Mitchell Rosner | Nephrology | Charlottesville, VA | $962.50 | 1 |
Ad
Manufacturing Companies
- bioMerieux $82,339
Product Information
- Type Device
- Total Payments $82,339
- Total Doctors 2
- Transactions 9
About NEPROCHECK
NEPROCHECK is a device associated with $82,339 in payments to 2 healthcare providers, recorded across 9 transactions in the CMS Open Payments database. The primary manufacturer is bioMerieux.
Payment data is available from 2020 to 2020. In 2020, $82,339 was paid across 9 transactions to 2 doctors.
The most common payment nature for NEPROCHECK is "Unspecified" ($82,339, 100.0% of total).
NEPROCHECK is associated with 4 research studies, including "LAPIS Trial: A Biomarker-Guided Implementation of Kidney-Sparing Care Measures to Prevent AKI in Sepsis Patients" ($59,877).